Literature DB >> 8155071

Sleep inducing effect of low energy emission therapy.

M Reite1, L Higgs, J P Lebet, A Barbault, C Rossel, N Kuster, U Dafni, D Amato, B Pasche.   

Abstract

The sleep inducing effect of a 15 min treatment with either an active or an inactive Low Energy Emission Therapy (LEET) device emitting amplitude-modulated electromagnetic (EM) fields was investigated in a double-blind cross-over study performed on 52 healthy subjects. All subjects were exposed to both active and inactive LEET treatment sessions, with an interval of at least 1 week between the two sessions. LEET consists of 27.12 MHz amplitude-modulated (sine wave) EM fields emitted intrabuccally by means of an electrically conducting mouthpiece in direct contact with the oral mucosa. The estimated local peak SAR is less than 10 W/kg in the oral mucosa and 0.1 to 100 mW/kg in brain tissue. No appreciable sensation is experienced during treatment, and subjects are therefore unable to tell whether they are receiving an active or an inactive treatment. In this study the active treatment consisted of EM fields intermittently amplitude-modulated (sine wave) at 42.7 Hz for 3 s followed by a pause of 1 s during which no EM fields were emitted. During the inactive treatment no EM fields were emitted. Baseline EEGs were obtained and 15 min post-treatment EEGs were recorded and analyzed according to the Loomis classification. A significant decrease (paired t test) in sleep latency to stage B2 (-1.78 +/- 5.57 min, P = 0.013), and an increase in the total duration of stage B2 (1.15 +/- 2.47 min, P = 0.0008) were observed on active treatment as compared with inactive treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8155071     DOI: 10.1002/bem.2250150110

Source DB:  PubMed          Journal:  Bioelectromagnetics        ISSN: 0197-8462            Impact factor:   2.010


  5 in total

1.  Electroencephalographic changes following low energy emission therapy.

Authors:  J P Lebet; A Barbault; C Rossel; Z Tomic; M Reite; L Higgs; U Dafni; D Amato; B Pasche
Journal:  Ann Biomed Eng       Date:  1996 May-Jun       Impact factor: 3.934

2.  Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.

Authors:  F P Costa; A C de Oliveira; R Meirelles; M C C Machado; T Zanesco; R Surjan; M C Chammas; M de Souza Rocha; D Morgan; A Cantor; J Zimmerman; I Brezovich; N Kuster; A Barbault; B Pasche
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

Review 3.  Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.

Authors:  Jacquelyn W Zimmerman; Hugo Jimenez; Michael J Pennison; Ivan Brezovich; Desiree Morgan; Albert Mudry; Frederico P Costa; Alexandre Barbault; Boris Pasche
Journal:  Chin J Cancer       Date:  2013-11

Review 4.  Low-energy amplitude-modulated radiofrequency electromagnetic fields as a systemic treatment for cancer: Review and proposed mechanisms of action.

Authors:  Jack A Tuszynski; Frederico Costa
Journal:  Front Med Technol       Date:  2022-09-08

5.  Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.

Authors:  Alexandre Barbault; Frederico P Costa; Brad Bottger; Reginald F Munden; Fin Bomholt; Niels Kuster; Boris Pasche
Journal:  J Exp Clin Cancer Res       Date:  2009-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.